MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
17.13
+0.10 (0.59%)
At close: Mar 13, 2026, 4:00 PM EDT
17.31
+0.18 (1.05%)
After-hours: Mar 13, 2026, 7:44 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $1.23 billion as of March 13, 2026. Its market cap has decreased by -53.52% in one year.
Market Cap
1.23B
Enterprise Value
910.44M
1-Year Change
-53.52%
Ranking
Category
Stock Price
$17.13
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.23B, an increase of 34,048.74%. That is a compound annual growth rate of 318.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.23B | 30.61% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapport Therapeutics | 1.33B |
| MBX Biosciences | 1.33B |
| Vir Biotechnology | 1.29B |
| Zenas BioPharma | 1.29B |
| Corvus Pharmaceuticals | 1.29B |
| Precigen | 1.24B |
| Immatics | 1.24B |
| Kodiak Sciences | 1.23B |